Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether use of exhaled NO (nitric oxide) to
regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in
patients with allergic asthma
Phase:
N/A
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Aerocrine AB Meda AB Merck Sharp & Dohme Corp. Phadia AB Region Stockholm Stockholm County Council, Sweden Swedish Council for Working Life and Social Research The Swedish Research Council Uppsala University